Table 1: Patient Characteristics.
BMI = Body mass index, FIGO = International Federation of Gynecology and Obstetrics.
†FIGO Staging not done on Melanoma (n = 10), or Neuro-endocrine tumours (n = 2).
Patient Characteristic | Study Group (n = 333) |
Age, years (Range 20 – 96) |
Mean | 67 |
Median | 71 |
Smoking status |
Current | 77 (23.1%) |
Former | 45 (13.5%) |
Never | 211 (63.2%) |
BMI (Range 14.6 – 54.7) |
< 20 | 13 (3.9%) |
20 - < 30 | 230 (69.1%) |
30 – 35 | 66 (19.8%) |
> 35 | 24 (7.2%) |
Diabetic |
Insulin dependent | 16 (4.8%) |
Non-Insulin dependent | 31 (9.3%) |
Histopathological sub-type |
Squamous cell carcinoma | 302 (90.7%) |
Melanoma | 10 (3%) |
Adenocarcinoma | 8 (2.4%) |
Sarcoma | 6 (1.8%) |
Other | 7 (2%) |
FIGO Stage 2009† |
1B | 182 (54.6%) |
11 | 12 (3.6%) |
111A (1) | 39 (11.7%) |
111A (11) | 15 (4.5%) |
111B (1) | 5 (1.5%) |
111B (11) | 11 (3.3%) |
111C | 42 (12.6%) |
1VA (1) | 3 (0.9%) |
1VA (11) | 7 (2.1%) |
1VB | 5 (1.5%) |
Groin Radiotherapy |
Neoadjuvant | 12 (3.6%) |
Adjuvant | 69 (20.7%) |